Drug
Zw191
Zw191: highest development phase Phase 1, developed by Zymeworks. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zymeworks
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZW191 NCT06555744 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Zw191 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.